Showing 3581-3590 of 10623 results for "".
RISK Cohort Study in Crohn's Disease
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/risk-cohort-study-crohns-disease/9924/Lu Ann Cahn talks w/ Dr. Piccoli about the RISK study that enrolled 1,800 patients & collected a variety of info to learn more about the immune systemSustained Mortality Risk Following COVID-19 Hospitalization
https://reachmd.com/programs/clinicians-roundtable/mortality-risk-covid-19-hospitalization/48840/Examining the Role of Bacterial Biofilms in Colorectal Cancer Screening
https://reachmd.com/programs/clinicians-roundtable/examining-the-role-of-bacterial-biofilms-in-colorectal-cancer-screening/33053/A recent clinical trial found that bacterial biofilms may be a valuable biomarker for colorectal cancer, showing the potential to enhance screening methods. Though more research is needed, the study’s conclusions on microbial colonization and polyp progression, procedural variables, and lifestyle faEvaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
https://reachmd.com/programs/clinicians-roundtable/evaluating-the-safety-of-ixekizumab-in-psoriasis-and-arthritis-patients/32447/Learn about the risk of adverse events associated with ixekizumab in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis.Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
https://reachmd.com/programs/neurofrontiers/metabolomics-in-multiple-sclerosis-advancing-diagnosis-prognosis-and-treatment-response/32373/Learn about recent research on metabolomics in multiple sclerosis and potential applications in patient care.Vutrisiran for ATTR-CM: Exploring an RNAi Therapeutic
https://reachmd.com/programs/spotlight-attr-cm/vutrisiran-for-attr-cm-exploring-an-rnai-therapeutic/32419/Read about recent clinical trial findings on vutrisiran, an RNA interference therapeutic that has emerged as a potential option for patients with transthyretin amyloid cardiomyopathy.Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
https://reachmd.com/programs/project-oncology/emerging-metastatic-breast-cancer-therapies-from-cdk-inhibitors-to-serds-and-beyond/26818/Tune in to learn about the emerging therapies for metastatic breast cancer.Getting to Know Gastroparesis
https://reachmd.com/programs/gi-insights/getting-to-know-gastroparesis/13936/Let’s take a deeper look at the complexity of gastroparesis. Find out what to look for in your patients.Accuracy of Online Estimates: An Update
https://reachmd.com/topics/energy-based-devices/accuracy-of-online-estimates-an-update/35189/Slight discrepancies between online estimates and actual procedure costs do not have a significant impact on patients’ decision to undergo treatmentsPatients’ Overall Skin Health Needs: Treating the Aesthetic Patient
https://reachmd.com/topics/skincare/patients-overall-skin-health-needs-treating-the-aesthetic-patient/35160/A look at the role aesthetic physicians can play in helping to manage patients’ medical dermatologic conditions